ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Tract Infections

COVID-19 trials near Valencia, VC, ESP:

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

This is a phase IIb/III, double-blind, randomised, active-controlled, multi-centre, non-inferiority clinical trial that aims to determine safety, tol...

Active, not recruiting
SARS-CoV2 Infection
Biological: PHH-1V81
Biological: Comirnaty Omicron XBB1.5

Phase 2, Phase 3

Hipra

Valencia, Spain and 9 other locations

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...

Enrolling
Sickle Cell Disease (SCD)
Drug: Crizanlizumab

Phase 2

Novartis
Novartis

Valencia, Spain and 56 other locations

The main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A i...

Active, not recruiting
Hemophilia A
Drug: BAX 888

Phase 1, Phase 2

Baxalta
Baxalta

Valencia, Spain and 27 other locations

The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr...

Enrolling
Allogeneic Hematopoietic Cell Transplant
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
Biological: tabelecleucel

Phase 3

Atara Biotherapeutics

Valencia, Spain and 70 other locations

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Placebo
Drug: Tozorakimab

Phase 3

AstraZeneca
AstraZeneca

Valencia, Spain and 380 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

Valencia, Spain and 246 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

Valencia, Spain and 496 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems